| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2844054 | M | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Influenza like illness
Influenza like illness
|
felt more like he had case of flu; This non-serious case was reported by a consumer via other manufa...
felt more like he had case of flu; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of influenza in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza (Verbatim: felt more like he had case of flu). The outcome of the influenza was resolved (duration 36 hrs). It was unknown if the reporter considered the influenza to be related to Shingrix. It was unknown if the company considered the influenza to be related to Shingrix. Additional Information: GSK Receipt Date: 28-MAY-2025 Reporter stated that after receiving Shingrix they felt more like patient had a case of flu. This case is linked with case US2025AMR066426, reported by the same reporter.; Sender's Comments: US-GSK-US2025AMR066426:same reporter/female patient
More
|
||||||||
| 2844055 | F | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Malaise
Malaise
|
feel a bit under the weather; This non-serious case was reported by a consumer via other manufacture...
feel a bit under the weather; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of feeling unwell in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Zostavax with an associated reaction of pruritus (received in 2012 and had arm itch for a week). On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced feeling unwell (Verbatim: feel a bit under the weather). The outcome of the feeling unwell was resolved (duration 36 hrs). It was unknown if the reporter considered the feeling unwell to be related to Shingrix. It was unknown if the company considered the feeling unwell to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR066426 Additional Information: GSK Receipt Date: 28-MAY-2025 Patient received first dose of Shingrix in 2018, which made her feel a bit under the weather on the day after. She was fine after 24-36 hours.; Sender's Comments: US-GSK-US2025AMR070488:same reporter/male patient US-GSK-US2025AMR066426:same patient/second dose
More
|
||||||||
| 2844056 | 19 | F | TN | 06/05/2025 |
HPV9 |
MERCK & CO. INC. |
Y013712 |
Extra dose administered
Extra dose administered
|
I accidentally gave the patient an extra dose of this vaccine because i did not realize her first do...
I accidentally gave the patient an extra dose of this vaccine because i did not realize her first dose was given when she was 12 years old. She would have only needed 2 doses.
More
|
||||||
| 2844057 | 64 | M | CO | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Fatigue, Headache, Pain
Fatigue, Headache, Pain
|
Fatigue, soreness, headaches lasting multiple days
Fatigue, soreness, headaches lasting multiple days
|
||||||
| 2844058 | 15 | F | TN | 06/05/2025 |
HPV9 |
MERCK & CO. INC. |
Y007197 |
Extra dose administered
Extra dose administered
|
Patient did not need third dose.
Patient did not need third dose.
|
||||||
| 2844059 | 16 | F | NY | 06/05/2025 |
HPV9 MENB |
MERCK & CO. INC. NOVARTIS VACCINES AND DIAGNOSTICS |
Y009051 |
Injection site nodule, Injection site pain; Injection site nodule, Injection sit...
Injection site nodule, Injection site pain; Injection site nodule, Injection site pain
More
|
Tender nodule in left deltoid, that measure 0.25 inch without: erythema, induration, swelling, and d...
Tender nodule in left deltoid, that measure 0.25 inch without: erythema, induration, swelling, and discoloration. Clinical Notes: May likely be lipohypertrophy or granulation due to HPV vaccine. Unlikely lipoma. No signs of infection or injury. Treatment: NSAIDs PRN and apply ice & heat. Recommended to RTC in 1 month for re-evaluation.
More
|
||||||
| 2844060 | 4 | F | MA | 06/05/2025 |
DTAPIPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
|
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
Child inadvertently received an extra dose of vaccine. No signs or symptoms of adverse outcome at th...
Child inadvertently received an extra dose of vaccine. No signs or symptoms of adverse outcome at this time.
More
|
||||||
| 2844061 | 68 | M | 06/05/2025 |
MENB MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS SANOFI PASTEUR |
7MN4C U8361AA |
Vaccination error; Vaccination error
Vaccination error; Vaccination error
|
Patient was administered a 3rd MenQuadfi dose in error
Patient was administered a 3rd MenQuadfi dose in error
|
|||||||
| 2844062 | M | 06/05/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
UNK |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
My baby was vaccinated at 6 months and 1 yr old; This non-serious case was reported by a consumer vi...
My baby was vaccinated at 6 months and 1 yr old; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of inappropriate age at vaccine administration in a male patient who received Men B NVS (Bexsero) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: My baby was vaccinated at 6 months and 1 yr old). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:02-JUN-2025 The patient was vaccinated with Bexsero at 6 months and 1 year old and asked if he need additional shots, which led to inappropriate age at vaccine administration.
More
|
||||||||
| 2844063 | 67 | M | PA | 06/05/2025 |
COVID19 |
PFIZER\BIONTECH |
ME6072 |
Chills, Pain, Pyrexia
Chills, Pain, Pyrexia
|
received covid vaccine on 6/3/2025 fever of 101.6 identified on 06/04/2025 with chills and body ache...
received covid vaccine on 6/3/2025 fever of 101.6 identified on 06/04/2025 with chills and body aches resolved with prn Tylenol 500 mg
More
|
||||||
| 2844064 | 22 | M | VA | 06/05/2025 |
TDAP |
SANOFI PASTEUR |
U7626AA |
Expired product administered
Expired product administered
|
a TDAP vaccine was given to a patient that had expired in 12/2024.
a TDAP vaccine was given to a patient that had expired in 12/2024.
|
||||||
| 2844065 | 0.5 | M | TX | 06/05/2025 |
DTAPHEPBIP HIBV PNC20 |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR PFIZER\WYETH |
5YB7L UK198AA LJ5282 |
Abnormal behaviour, Sleep disorder; Abnormal behaviour, Sleep disorder; Abnormal...
Abnormal behaviour, Sleep disorder; Abnormal behaviour, Sleep disorder; Abnormal behaviour, Sleep disorder
More
|
The mother reports that on the same day (04/15/2025) that the patient received his vaccines his beha...
The mother reports that on the same day (04/15/2025) that the patient received his vaccines his behavior changed: 1) his normal crying and babbling sounds were reduced to muffled moans; 2) his usual calm behavior, for example, during breast feeding, changed to hitting, biting and clawing actions 'as if desperate'; 3) he was clingy and didn't want to be put down; 4)he was no longer sleeping well. The mother brought the patient back into the office on 05/01/2025 because these behaviors had persisted for over 2 weeks and she was concerned that they were vaccine-related. The mother reports that she noted that the patient's behaviors had fully returned to normal when she heard the patient cry normally on 05/05/2025.
More
|
||||||
| 2844066 | 11 | M | MI | 06/05/2025 |
MENB |
PFIZER\WYETH |
HP9988 |
No adverse event, Wrong product administered
No adverse event, Wrong product administered
|
Patient was given incorrect vaccine. Patient given MenB-FHbp (Trumemba). Order was for MenACWY-TT ...
Patient was given incorrect vaccine. Patient given MenB-FHbp (Trumemba). Order was for MenACWY-TT (MenQuadfi). No adverse affect to the patient. No harm to the patient.
More
|
||||||
| 2844067 | 1 | M | CO | 06/05/2025 |
HIBV HIBV MMR MMR PNC20 PNC20 |
SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. PFIZER\WYETH PFIZER\WYETH |
UK210AA UK210AA Y004114 Y004114 HR3650 HR3650 |
Blood glucose decreased, Ear infection, Hypophagia, Lethargy, Oliguria; Pyrexia;...
Blood glucose decreased, Ear infection, Hypophagia, Lethargy, Oliguria; Pyrexia; Blood glucose decreased, Ear infection, Hypophagia, Lethargy, Oliguria; Pyrexia; Blood glucose decreased, Ear infection, Hypophagia, Lethargy, Oliguria; Pyrexia
More
|
5/22-5/25: Child had low grade fever, lethargy, not eating/drinking much per MOC. 5/26 child spiked ...
5/22-5/25: Child had low grade fever, lethargy, not eating/drinking much per MOC. 5/26 child spiked 101 fever and was seen by PCP 5/27 child was brought to ER by MOC for fever 105 not dropping with medication, low urine output, lethargy, low BS. Child was dx with ear infection and stared on Amoxicillin. Administered IVF and fever reducing meds and child was discharged. 5/28 child's fever was better but still not eating/drinking. 5/29 child was sent via ambulance back to ER after broke out in facial rash, fever, lethargy, low UO. Per MOC ER administered benedryl and believed it to be a abx related rash. Kept child on amoxicillin. Rash described as red, raised, started on face and moved down body. Child was inpt x 3 days and sent home on 5/31. Fever, rash and lethargy have resolved.
More
|
โ | |||||
| 2844068 | 51 | F | 06/05/2025 |
PNC21 |
MERCK & CO. INC. |
Y019157 |
Haemorrhage, Immediate post-injection reaction, Swelling
Haemorrhage, Immediate post-injection reaction, Swelling
|
Pt had a lot of swelling and bleeding immediately after the vaccination. She did not have any signs ...
Pt had a lot of swelling and bleeding immediately after the vaccination. She did not have any signs of an allergic reaction. I called her one hour later and it was still swollen but no other symptoms.
More
|
|||||||
| 2844069 | 61 | F | CT | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
FJ9A7 |
Vomiting
Vomiting
|
Patient reported she Vomited afterwards
Patient reported she Vomited afterwards
|
||||||
| 2844070 | 52 | M | VA | 06/05/2025 |
PNC20 VARZOS |
PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
LK6650 7ZM55 |
Injection site rash, Injection site warmth, Pain in extremity; Injection site ra...
Injection site rash, Injection site warmth, Pain in extremity; Injection site rash, Injection site warmth, Pain in extremity
More
|
Patient came into pharmacy with complaint of pain in left arm with visible rash from shoulder to elb...
Patient came into pharmacy with complaint of pain in left arm with visible rash from shoulder to elbow. Pt reported that it started the day after the vaccine and only had pain which he treated with tylenol. Rash came about lunchtime next day and has been spreading towards elbow and it hot to touch and has some pain.
More
|
||||||
| 2844071 | 38 | F | LA | 06/05/2025 |
TDAP |
SANOFI PASTEUR |
3CA17C1 |
Bell's palsy, Facial paralysis, Facial paresis
Bell's palsy, Facial paralysis, Facial paresis
|
Pt is G3P2 at 36w3d at time of vaccination. Pt began having facial droop/weakness about 7 hours afte...
Pt is G3P2 at 36w3d at time of vaccination. Pt began having facial droop/weakness about 7 hours after vaccination and was diagnosed with Bell's palsy.
More
|
||||||
| 2844072 | 41 | F | NH | 06/05/2025 |
UNK |
UNKNOWN MANUFACTURER |
Y019158 |
Hypoaesthesia, Peripheral coldness
Hypoaesthesia, Peripheral coldness
|
5/30--pt received PCV21 in R deltoid. Pt notes both arms with intermittent numbness since Friday nig...
5/30--pt received PCV21 in R deltoid. Pt notes both arms with intermittent numbness since Friday night and coldness in hands--no discoloration. Denies tingling or weakness--pt notes numbness resolved yesterday and per her research PCV21 can cause some numbness a few days after immunization. Pt notes injection site tender to touch but no pain with movement. Redness noticed today, +warmth to touch. Oval shaped redness 3.5 x 2 inches. Denies red streaking, drainages, fevers, SOB, wheezing, swelling of face/lips/tongue
More
|
||||||
| 2844073 | 73 | F | OK | 06/05/2025 |
COVID19 |
MODERNA |
O32H21A |
Amnesia, Craniofacial fracture, Fall, Shoulder fracture, Wrist fracture
Amnesia, Craniofacial fracture, Fall, Shoulder fracture, Wrist fracture
|
I was in town for the booster, we were exiting the expo for Christmas. I had been standing for a hou...
I was in town for the booster, we were exiting the expo for Christmas. I had been standing for a hour and all i could remember was exiting on the east side holding the door open with my right hand, i don't remember my head turning around or anything i woke up in an ambulance with them asking who should we contact. And then i kinda don't remember too much of anything until i was in the exam room , my glasses were knocked off my shoe was knocked off and it was on concrete and i had tripped over that concrete bumper and there was a brick wall behind it 2.5 feet away and i was laying between the both i had fallen on my left side. I broke my shoulder and my wrist and the left side of my face. I went to see a facial surgeon and my doctor and i got an eye exam done.
More
|
||||||
| 2844074 | 1.25 | F | MN | 06/05/2025 |
PNC20 |
PFIZER\WYETH |
MF0425 |
Injection site erythema, Irritability
Injection site erythema, Irritability
|
Raised red mark surrounding the injection. Very irritable the morning after the injection and days a...
Raised red mark surrounding the injection. Very irritable the morning after the injection and days after
More
|
||||||
| 2844075 | 63 | F | TX | 06/05/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
XX9N4 |
Arthralgia, Hypersomnia, Inflammation, Musculoskeletal stiffness, Pain in extrem...
Arthralgia, Hypersomnia, Inflammation, Musculoskeletal stiffness, Pain in extremity
More
|
Hands and feet/ankles began hurting (stiff and painful) approximately 2 weeks after vaccination. My ...
Hands and feet/ankles began hurting (stiff and painful) approximately 2 weeks after vaccination. My feet/ankles are mostly okay, but will stiffen up after sleep, rest, and walking). Hands, and especially right hand, are inflamed. I have been sleeping more, but more likely because of my back and sciatica pain.
More
|
||||||
| 2844077 | 67 | M | CO | 06/05/2025 |
HEPAB HEPAB VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
344J3 344J3 3J252 3J252 |
Arthralgia, Headache, Ligament sprain, Lip blister, Pain in extremity; Pruritus;...
Arthralgia, Headache, Ligament sprain, Lip blister, Pain in extremity; Pruritus; Arthralgia, Headache, Ligament sprain, Lip blister, Pain in extremity; Pruritus
More
|
After receiving the shingles vaccine I developed blisters on my upper lip that were present for 2 da...
After receiving the shingles vaccine I developed blisters on my upper lip that were present for 2 days, My left wrist felt like it was sprained. Mild Arthritis pain in thumbs and fingers became extreme pain, Constant headaches, still to this day. My knees are both hurting ion the joints and I have NEVER had knee pain. Plus I have episodes of itching, all over my body. Especially at night and it wakes me up.
More
|
||||||
| 2844078 | 0.5 | M | VA | 06/05/2025 |
DTPPVHBHPB DTPPVHBHPB DTPPVHBHPB PNC20 PNC20 PNC20 RV5 RV5 RV5 |
MSP VACCINE COMPANY MSP VACCINE COMPANY MSP VACCINE COMPANY PFIZER\WYETH PFIZER\WYETH PFIZER\WYETH MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
U7623AA U7623AA U7623AA LN4929 LN4929 LN4929 2052023 2052023 2052023 |
Dehydration, Diarrhoea, Erythema, Hypophagia, Lethargy; Nasal congestion, Pallor...
Dehydration, Diarrhoea, Erythema, Hypophagia, Lethargy; Nasal congestion, Pallor, Pyrexia, Retching, Secretion discharge; Vomiting; Dehydration, Diarrhoea, Erythema, Hypophagia, Lethargy; Nasal congestion, Pallor, Pyrexia, Retching, Secretion discharge; Vomiting; Dehydration, Diarrhoea, Erythema, Hypophagia, Lethargy; Nasal congestion, Pallor, Pyrexia, Retching, Secretion discharge; Vomiting
More
|
Chief Complaint Vomiting yellow-green bile for over 1.5 hours yesterday, lethargy, pallor, dehydrati...
Chief Complaint Vomiting yellow-green bile for over 1.5 hours yesterday, lethargy, pallor, dehydration requiring ER visit and IV fluids History of Present Illness Patient, an infant male with a recent history of adenovirus and parainfluenza 3 in early May, presents for follow-up after an emergency room visit and hospitalization due to acute vomiting and lethargy. Yesterday, around 2:30 PM, while napping in his swing, patient began vomiting. The vomiting episodes occurred every 1-2 minutes, progressing from what appeared to be a mix of spit-up and vomit to yellow-green bile. The episodes continued until after 4 PM. Accompanying symptoms included pallor, lethargy, and refusal to nurse. Patient's mother reports he became pale, with his lips losing color, and he didn't smile. He was gagging, whimpering, and dry-heaving, with his face turning red during episodes. His grandmother noted he looked gray. Due to the severity of symptoms, patient was taken to the emergency room where he received IV fluids, labs, and imaging studies. The ER pediatrician initially suspected a possible partial intussusception based on x-ray findings. Patient was transferred by ambulance to another hospital for further evaluation, where repeat scans were normal. He regained his color by 9 PM and stopped vomiting after 7 PM. He received IV fluids and was able to nurse before being discharged with instructions to follow up with the pediatrician. Since discharge, patient has been tired but nursing normally. He hasn't had any solid foods. This morning at 11 AM, he had light brown diarrhea. The mother notes that patient had a slight fever from shots on Friday, but has no fever now. She also mentions that his stool on Saturday night was mucousy, which she attributes to the rotavirus vaccine. Today, patient appears pale with some nasal contractions. The mother reports that patient had adenovirus and parainfluenza 3 in early May, which caused yellow diarrhea. She states he hasn't had any bloody or mucousy stools indicative of intussusception. The mother mentions that patient had avocado yesterday morning, which she suspects might be linked to his symptoms. Medical History - Emergency room visit and hospitalization for severe vomiting and dehydration - Adenovirus and parainfluenza 3 infections in early May - Vaccinations received, including rotavirus vaccine Medications and Supplements - Rotavirus vaccine - Administered Friday - Side effect: Mucousy poop on Saturday night Social History - Living Situation: Lives with parents - Diet: Exclusively breastfed, no solid foods introduced yet except for recent avocado trial - Caretaker Arrangement: Primary care provided by mother, grandmother involved in care Review of Systems General: Positive for fatigue, lethargy, pallor. Negative for fever. HEENT: Positive for nasal contractions. Respiratory: Positive for whimpering. Gastrointestinal: Positive for vomiting, diarrhea. Negative for bloody stools.
More
|
||||||
| 2844079 | 11 | M | NC | 06/05/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
DL4YY |
Injection site erythema, Injection site pruritus, Injection site swelling
Injection site erythema, Injection site pruritus, Injection site swelling
|
Redness & swelling & some itching at injection site; itching that worsened over past 2 days
Redness & swelling & some itching at injection site; itching that worsened over past 2 days
|
||||||
| 2844080 | 42 | F | WA | 06/05/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
023C21A 050C21A |
Menstruation irregular; Menstruation irregular
Menstruation irregular; Menstruation irregular
|
Before I was given any Covid vaccine, I had regularly monthly menstruation. So regular it started ev...
Before I was given any Covid vaccine, I had regularly monthly menstruation. So regular it started every 28 days and lasted 4 days. Every month. However, after receiving the vaccines my monthly menstruation completely stopped being regular, meaning I wasn?t menstruating monthly any longer. I went from monthly and regular to sporadic and maybe 3-4 times per year for the first year after the vaccine. The second year I menstruated no more than 3 times, the third and year post vaccine I had maybe 1 period. This year I menstruated one time for two days. This is concerning, not so much for me, but for younger people who are trying to have babies.
More
|
โ | |||||
| 2844081 | 77 | M | FL | 06/05/2025 |
COVID19 TDAP |
PFIZER\BIONTECH GLAXOSMITHKLINE BIOLOGICALS |
MD3414 39lb7 |
Back pain, Pain in extremity, Pyrexia; Back pain, Pain in extremity, Pyrexia
Back pain, Pain in extremity, Pyrexia; Back pain, Pain in extremity, Pyrexia
|
patient stated he was running a fever and his left arm and back were aching, he stated he took some ...
patient stated he was running a fever and his left arm and back were aching, he stated he took some tylenol and it temporarily relieves the symptoms. I advised patient to seek medication attention if his symptoms became severe, if he developed a rash, or developed shortness of breath
More
|
||||||
| 2844082 | 11 | F | GA | 06/05/2025 |
MNQ TDAP |
NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS |
AMBV064A KR75K |
Pruritus; Pruritus
Pruritus; Pruritus
|
BODY WIDE PRUITITS 15 MINUTES POST VACCINES. ITCHING RESOLVED WITHIN 24 HOURS AFTER VACCINE ADMINIS...
BODY WIDE PRUITITS 15 MINUTES POST VACCINES. ITCHING RESOLVED WITHIN 24 HOURS AFTER VACCINE ADMINISTRATION.
More
|
||||||
| 2844083 | 15 | F | FL | 06/05/2025 |
HPV9 IPV TDAP VARCEL |
MERCK & CO. INC. SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
Y013407 Y1A212M L5229 Y015559 |
Extra dose administered; Extra dose administered; Extra dose administered; Extra...
Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered
More
|
Other language speaking pt here with dad and sibling. Language line interpreter #463318 and #425625 ...
Other language speaking pt here with dad and sibling. Language line interpreter #463318 and #425625 used in succession during appt. During assessment of vaccines it was determined that Tdap, IPV, HPV and VAR were needed. LMP- 05/20/25. NKA. No sig med hx per pts dad. All vaccines administered IM. Upon entering vaccines into database, it was realized that pt was already complete with VAR and therefore received an extra dose. Dad made aware and instructed on s/s to watch out for-temp over 104.0, seizures, sob, lethargy. Also instructed if any concerns or issues develop to RTC or seek ER care. Dad stated via interpreter "That is fine". Pt BP taken on L arm-118/78, pulse-83. Medical Executive Director contacted due to nature of incident and received instructions to make pt aware of s/s to watch for as stated above. Pt remained in clinic 30 min after vaccines were administered and stated via interpreter "I feel fine".
More
|
||||||
| 2844084 | 24 | M | TX | 06/05/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
T5D73 |
Diarrhoea, Nausea, Vomiting
Diarrhoea, Nausea, Vomiting
|
Patient returned(06/05/2025) one month later to receive the Hep A vaccine, however, his lab shows po...
Patient returned(06/05/2025) one month later to receive the Hep A vaccine, however, his lab shows positive titers for Hep A. Pt reported that after he received the Hep B vaccine on 05/05/2025, that "a few hours" later he began experiencing nausea vomiting and diarrhea. Patient was seen in the ED the next day for these symptoms. Patient reports today that his symptoms improved.
More
|
||||||
| 2844085 | 1.42 | M | CO | 06/05/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
DN273 |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Patient was given Havrix 13 days early and off schedule.
Patient was given Havrix 13 days early and off schedule.
|
||||||
| 2844086 | 45 | F | PR | 06/05/2025 |
HPV9 |
MERCK & CO. INC. |
Z005469 |
Induration, Peripheral swelling, Tenderness
Induration, Peripheral swelling, Tenderness
|
Patient came to the pharmacy to report that she had a severe localized reaction to Gardasil. She sai...
Patient came to the pharmacy to report that she had a severe localized reaction to Gardasil. She said that her arm is very swollen, tender, and hard to the touch. We advise her to apply cold compresses and referred to her doctor for evaluation.
More
|
||||||
| 2844087 | 39 | M | OH | 06/05/2025 |
COVID19 TDAP |
PFIZER\BIONTECH GLAXOSMITHKLINE BIOLOGICALS |
LN0590 9N4E7 |
Arthralgia, Loss of personal independence in daily activities, Mobility decrease...
Arthralgia, Loss of personal independence in daily activities, Mobility decreased; Arthralgia, Loss of personal independence in daily activities, Mobility decreased
More
|
shoulder pain and declined ROM within 2 hours of shots and lasting over 4 weeks. limiting activities
shoulder pain and declined ROM within 2 hours of shots and lasting over 4 weeks. limiting activities
|
||||||
| 2844088 | 68 | F | OR | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Arthralgia, Diarrhoea, Joint swelling, Pain
Arthralgia, Diarrhoea, Joint swelling, Pain
|
Multiple arthralgias and multiple swollen joints. acute diarrhea, body pain. Started approx 24 hours...
Multiple arthralgias and multiple swollen joints. acute diarrhea, body pain. Started approx 24 hours after vaccination, causing intense pain.
More
|
||||||
| 2844089 | 56 | F | CO | 06/05/2025 |
PNC20 |
PFIZER\WYETH |
ln4927 |
Erythema, Swelling
Erythema, Swelling
|
pt presented with swelling and erythema. No fever noted
pt presented with swelling and erythema. No fever noted
|
||||||
| 2844090 | 4 | F | FL | 06/05/2025 |
DTAPIPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
5G23D y016872 |
Injection site cellulitis, Injection site rash, Injection site warmth; Injection...
Injection site cellulitis, Injection site rash, Injection site warmth; Injection site cellulitis, Injection site rash, Injection site warmth
More
|
1 day after the vaccine, a rash showed up on Left thigh near injection site It started to spread and...
1 day after the vaccine, a rash showed up on Left thigh near injection site It started to spread and has spread across her thigh, it's hot to touch. No fevers. Patient seen in office 3 days after vaccines given and diagnosed with cellulitis at injection site. patient started on cephalexin to treat infection
More
|
||||||
| 2844091 | 75 | F | IL | 06/05/2025 |
COVID19 |
PFIZER\BIONTECH |
MD3414 |
Paraesthesia, Paraesthesia oral
Paraesthesia, Paraesthesia oral
|
Starting experiencing tingling in extremities (hands, and feet) yesterday. Today (6-5-2025) startin...
Starting experiencing tingling in extremities (hands, and feet) yesterday. Today (6-5-2025) starting experiencing tingling on tongue
More
|
||||||
| 2844092 | 55 | F | 06/05/2025 |
HPV9 PNC20 VARZOS |
MERCK & CO. INC. PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
|
Injection site erythema, Injection site pruritus, Injection site swelling; Injec...
Injection site erythema, Injection site pruritus, Injection site swelling; Injection site erythema, Injection site pruritus, Injection site swelling; Injection site erythema, Injection site pruritus, Injection site swelling
More
|
patient stated that the same day she received the 3 vaccines she began experiencing itching, redness...
patient stated that the same day she received the 3 vaccines she began experiencing itching, redness, and swelling in the area of her arm that the vaccines were given,...the area became larger after a 6 day time frame
More
|
|||||||
| 2844093 | 21 | F | IA | 06/05/2025 |
HEP HEP HEP HEP HEPAB |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
PE9G5 UNK |
Antibody test negative, Expired product administered, Incomplete course of vacci...
Antibody test negative, Expired product administered, Incomplete course of vaccination; Antibody test negative, Expired product administered, Incomplete course of vaccination; Antibody test negative, Expired product administered, Incomplete course of vaccination; Antibody test negative, Expired product administered, Incomplete course of vaccination; Antibody test negative, Expired product administered, Incomplete course of vaccination
More
|
they got an antibody test and it came negative; incomplete course of vaccination; patients received ...
they got an antibody test and it came negative; incomplete course of vaccination; patients received an expire dose of Engerix-B; This non-serious case was reported by a nurse via call center representative and described the occurrence of therapy non-responder in a 21-year-old female patient who received HBV (Engerix B) (batch number PE9G5, expiry date 19-MAY-2025) for prophylaxis. Co-suspect products included HAB (Twinrix) for prophylaxis, HBV (Engerix B) for prophylaxis, HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis. Concomitant products included Hepatitis a vaccine inact, Hepatitis b vaccine rHBsAg (yeast) (Twinrix). On 28-MAY-2025, the patient received the 4th dose of Engerix B. The patient did not receive the 2nd dose of Twinrix, on an unknown date, the patient received the 3rd dose of Engerix B, the 2nd dose of Engerix B and the 1st dose of Engerix B. On 28-MAY-2025, an unknown time after receiving Engerix B and not applicable after receiving Twinrix, Engerix B, Engerix B and Engerix B, the patient experienced expired vaccine used (Verbatim: patients received an expire dose of Engerix-B). On an unknown date, the patient experienced therapy non-responder (Verbatim: they got an antibody test and it came negative) and incomplete course of vaccination (Verbatim: incomplete course of vaccination). The outcome of the therapy non-responder, expired vaccine used and incomplete course of vaccination were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-MAY-2025 Nurse called and reported that one of their patients received an expire dose of Engerix-B, the vaccination date was 28-May-2025 and the vaccine was expired since 19-May-2025, which led to expired vaccine used. The patient had 3 doses a long time ago, so this was the 5th dose, they had 3 doses when they were a child, and then they were going to school, colleague, and they got an antibody test and it came negative, which led to Therapy non-responder. So they want attempt start over, so she had a Twinrix on 20-Apr-2025. Till the time of reporting the patient did not receive the second dose of Twinrix, which led to incomplete course of vaccination.
More
|
||||||
| 2844094 | AL | 06/05/2025 |
DTAP DTAPHEPBIP DTAPIPV HEP HEPA HIBV MENB MNQ TDAP |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS |
|
Product storage error; Product storage error; Product storage error; Product sto...
Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error; Product storage error
More
|
Product Storage error with vaccine administration outside stability conditions / some patients got v...
Product Storage error with vaccine administration outside stability conditions / some patients got vaccinated with those products; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis, HBV (Engerix B) for prophylaxis, Hib (Hiberix) for prophylaxis, HAV (Havrix) for prophylaxis, DTPa (Infanrix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis and DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patients received Bexsero, Boostrix, Engerix B, Hiberix, Havrix, Infanrix, Kinrix, Menveo and Pediarix. On an unknown date, an unknown time after receiving Bexsero, Boostrix, Engerix B, Hiberix, Havrix, Infanrix, Kinrix, Menveo and Pediarix, the patient experienced incorrect storage of drug (Verbatim: Product Storage error with vaccine administration outside stability conditions / some patients got vaccinated with those products). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-JUN-2025 The Vaccine Administration Facility was the same as Primary Reporter. The Medical Assistant called to report about a below freezing temperature excursion and reactively mentioned that he/she not aware of this information and some patients got vaccinated with those products. According to Medical Assistant precision, multiple patients were vaccinated Bexsero, Boostrix, Engerix B, Hiberix, Havrix, Infanrix, Kinrix, Menveo and Pediarix which led to incorrect storage of drug. No specific information about vaccination date, vaccine detail and patient demographics were obtained in this call No further information was obtained in this call.
More
|
||||||||
| 2844095 | F | NY | 06/05/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
D23D3 |
Expired product administered
Expired product administered
|
Expired Product Used; This non-serious case was reported by a pharmacist via call center representat...
Expired Product Used; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) (batch number D23D3, expiry date 15-MAR-2025) for prophylaxis. On 02-JUN-2025, the patient received Engerix B. On 02-JUN-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Expired Product Used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:03-JUN-2025 The reporter reported that administration of an expired dose of Engerix-B the day before reporting to a patient, which led to expired vaccine used. The reporter asked if there was any data on when to repeat the dose of Engerix-B. The reporter consented to follow up.
More
|
|||||||
| 2844096 | 41 | F | GA | 06/05/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
32YB4 |
Product preparation issue
Product preparation issue
|
Incorrect Preparation/nurses administered just the diluent portion; Incorrect Preparation/nurses adm...
Incorrect Preparation/nurses administered just the diluent portion; Incorrect Preparation/nurses administered just the diluent portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 41-year-old female patient who received MMR (Priorix) (batch number 32YB4, expiry date 01-DEC-2026) for prophylaxis. On 02-JUN-2025, the patient received Priorix. On 02-JUN-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Incorrect Preparation/nurses administered just the diluent portion) and inappropriate dose of vaccine administered (Verbatim: Incorrect Preparation/nurses administered just the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter had one of our nurses administered just the diluent portion, missed to combine the vial, the powder and just wanted to know when they should try to re-administer the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
More
|
||||||
| 2844097 | 67 | M | UT | 06/05/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Expired product administered
Expired product administered
|
Expired dose administered; This non-serious case was reported by a pharmacist via call center repres...
Expired dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 31-MAR-2025) for prophylaxis. On 02-JUN-2025, the patient received Arexvy. On 02-JUN-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date:03-JUN-2025 Pharmacist reported that a patient received Arexvy the day before reporting, which led to expired vaccine used. The reporter consented to follow up
More
|
||||||
| 2844098 | F | FL | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
Shingrix + Late 2nd dose; This non-serious case was reported by a pharmacist via call center represe...
Shingrix + Late 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (On 18-FEB-2021, the patient got the first dose). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Shingrix + Late 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 03-JUN-2025 The pharmacist called to confirm if what a physician said was true. The physician said Shingrix should be restarted if more than 6 months had passed after the first dose. The reporter did not consent to follow-up. The Vaccine Administration Facility is the same as Primary Reporter.
More
|
|||||||
| 2844099 | 16 | F | VA | 06/05/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
AMVB030A |
Expired product administered
Expired product administered
|
Expired dose administered.; This non-serious case was reported by a other health professional via ca...
Expired dose administered.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB030A, expiry date 30-APR-2025) for prophylaxis. On 03-JUN-2025, the patient received Menveo. On 03-JUN-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired dose administered.). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter had a patient received Menveo at the time of reporting, but it was expired, which led to expired vaccine used. They were wondering when we should revaccinate. The reporter consented to follow up by email.
More
|
||||||
| 2844100 | F | CO | 06/05/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
A female patient around 50 years old received Havrix on 2018 and did not complete the series.; This ...
A female patient around 50 years old received Havrix on 2018 and did not complete the series.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 50-year-old female patient who received HAV (Havrix) for prophylaxis. Previously administered products included Havrix (received one dose in 2018). On an unknown date, the patient did not receive Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incomplete course of vaccination (Verbatim: A female patient around 50 years old received Havrix on 2018 and did not complete the series.). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter called to report that a patient around 50 years old who received a dose of Havrix on 2018 and had not completed the dosing schedule for Havrix. The reporter asked if she could get Twinrix. The reporter consented to follow up. Till the time of reporting, the patient did not receive the further dose of Havrix, which led to incomplete course of vaccination.
More
|
|||||||
| 2844101 | IA | 06/05/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Kinrix plus use as 4th Dtap; This non-serious case was reported by a other health professional via s...
Kinrix plus use as 4th Dtap; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate schedule of vaccine administered in a patient who received DTPa-IPV (Kinrix) for prophylaxis. On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Kinrix plus use as 4th Dtap). The outcome of the inappropriate schedule of vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-JUN-2025 Patient got Kinrix last year when she was behind on vaccine, still 5 years old and still behind on Dtap and polio which led to inappropriate schedule of vaccine administered. The reporter enquired could she do a 2nd Kinrix this year.
More
|
||||||||
| 2844102 | 50 | M | MD | 06/05/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
now want to receive 2nd dose; This non-serious case was reported by a pharmacist via call center rep...
now want to receive 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2023 with batch number YC51Y7). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: now want to receive 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 04-JUN-2025 The registered pharmacist wanted to know how to proceed with a patient that received the first dose of Shingrix back in 2023 and now wanted to receive the second dose. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine which led to incomplete course of vaccination.
More
|
||||||
| 2844103 | F | TX | 06/05/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
XS27B |
Expired product administered
Expired product administered
|
expiration date was on 17 March 2025, and it was administered to a 22 year old; This non-serious cas...
expiration date was on 17 March 2025, and it was administered to a 22 year old; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received HBV (Engerix B) (batch number XS27B, expiry date 17-MAR-2025) for prophylaxis. On 04-JUN-2025, the patient received the 1st dose of Engerix B. On 04-JUN-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: expiration date was on 17 March 2025, and it was administered to a 22 year old). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-JUN-2025 On 4 June 2025 a pharmacist of called to asked how to proceed after the administration of an expired dose of Engerix-B. The expiration date was on 17th March 2025, and it was administered to a 22 year-old female patient on 4 June 2025, which led to Expired vaccine used. It was for the first dose. The reporter was consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.
More
|
|||||||
| 2844104 | F | 06/05/2025 |
COVID19 |
MODERNA |
|
Neuropathy peripheral
Neuropathy peripheral
|
One lady had neuropathy; This female subject of an unknown age was involved in an other study and re...
One lady had neuropathy; This female subject of an unknown age was involved in an other study and received COVID-19 VACCINE MRNA (SPIKEVAX COVID-19 VACCINE NOS) for COVID-19 prophylaxis. The report describes a case of NEUROPATHY PERIPHERAL (One lady had neuropathy). No Medical History information was reported. On an unknown date, the subject received dose of COVID-19 VACCINE MRNA (SPIKEVAX COVID-19 VACCINE NOS) (unknown route) 1 dosage form at an unspecified frequency. On an unknown date, the subject experienced NEUROPATHY PERIPHERAL (One lady had neuropathy) (seriousness criterion medically significant). At the time of the report, NEUROPATHY PERIPHERAL (One lady had neuropathy) outcome was unknown. The action taken with COVID-19 VACCINE MRNA (SPIKEVAX COVID-19 VACCINE NOS) (Unknown) was unknown. For COVID-19 VACCINE MRNA (SPIKEVAX COVID-19 VACCINE NOS) (Unknown), the reporter did not provide any causality assessments. ID was reported as DCP-0420-25. Regulatory Authority name was reported as mRNA-1083 Life Cycle Management Concept Evaluation. Concomitant medication use information was not provided by reporter. Treatment medication use information was not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2025-786903 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 22-May-2025: Live follow up received that contains no new information. On 26-May-2025: Live follow up received that contains no new information. On 27-May-2025: Live follow up received that contains significant information includes added Regulatory Authority number and narrative was updated.; Reporter's Comments: The reporter causality for the event was not provided. The company causality was assessed conservatively as related to the vaccine in the context of limited information available. The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-786903:Female patient
More
|